ABSTRACT
Background: Coeliac disease (CD) is an immune-mediated
enteropathy that causes intestinal villous atrophy and malabsorption. One of
the malabsorbed micronutrients is vitamin D.
Objective: This retrospective study analysed
epidemiological aspects of Jordanian CD patients, their serum vitamin D levels
and anti-tissue transglutaminase (tTG) IgA and IgG antibody levels at King
Hussein Medical Centre.
Methods: In this retrospective analysis we identified
116 biopsy-proven CD patients between 2016 and 2019. The computerized patient
record system was the referral source for the following clinical and laboratory
parameters: age, gender, presenting symptoms, serum 25-hydroxyvitamin D3 level
and anti-tTG IgA and IgG antibody levels. Data were analysed with SPSS version
26 software for statistical significance using the Mann-Whitney U test; a p value of < 0.05 was considered to
be significant.
Results:
116 CD patients
showed female predominance, with a female/male ratio of 1.8:1, and an age range
of 3–78 years. Seventeen patients (15%) were asymptomatic. Positive serum tTG
IgA or IgG antibodies, or both, were found in 81 patients (69.8%). Sixty
patients (51.73%) were vitamin D deficient, 41 (35.33%) were insufficient and
15 (12.93%) had sufficient levels. No correlation was found between any
parameters apart from a positive correlation between tTG IgA and IgG antibodies
(p = 0.009).
Conclusion: Vitamin D deficiency is common in CD patients
and should be ruled out regardless of age, presenting symptoms or anti-tTG
antibody status.
Keywords: coeliac disease; vitamin D deficiency.
Introduction
Coeliac disease (CD) is a multifactorial
systemic inflammatory disorder characterized by an abnormal immune response
elicited by dietary gluten and has an approximate global prevalence rate of 1%
(1).
The clinical
picture includes an array of gastrointestinal and non-gastrointestinal
symptoms, short stature, decreased bone density, dermatitis herpetiformis,
dental problems, iron-deficiency anaemia and hepatitis (2). Gluten is a group
of storage proteins that can be found in wheat, rye and barley, among other
grains (3). It is mainly composed of gliadin and glutenin subunits, which, due
to their resistance to gastric and pancreatic enzymes, reach the proximal small
intestine partially indigested, where tissue transglutaminase (tTG) catalyses
their deamination; they are then linked to HLA-DQ2 or DQ8 molecules, increasing
their immunogenicity and subsequent activation of helper T cells (4). Due to
mucosal injury, nutrient malabsorption occurs with an ensuing deficiency of the
fat-soluble vitamins A, D, E and K (5).
This study
analysed 116 CD patients and compared their serum levels of vitamin D and
anti-tTG antibodies.
MATERIALS
AND METHODS
We acquired the approval of the ethics
committee of the Royal Medical Services, Amman, Jordan. This retrospective
study was conducted on 116 CD patients identified using our laboratory database
during the time period between 2016 and 2019.
We referred to electronic medical records to acquire the following data:
age, gender, presenting symptoms, serum 25-hydroxyvitamin D3 (25(OH)D3) level using
Cobas e411 analyser and tTG IgA and IgG antibody levels using ELISA technique.
Anti-tTG IgA
and IgG antibody assays were considered positive at values of > 10 and >
9 U/ml, respectively. Subjects were divided into three groups according to
their serum 25(OH)D3 levels: vitamin D deficient [25(OH)D3 < 20 ng/ml],
insufficient [25(OH)D3 20–30 ng/ml] and sufficient [25(OH)D3 >30
ng/ml].
Statistical
analysis
Management and
statistical analysis of the data was performed using SPSS version 26 software
(SPSS Inc., Chicago, IL, USA) and the Microsoft Excel 2007 program. Descriptive
data were reported as percentages of the total number of identified CD
patients. Means and standard deviations (SD) were calculated and a p value below 0.05 was considered to be
statistically significant. Non-parametric analysis using the Mann-Whitney U
test was carried out on two independent groups based on gender.
RESULTS
A total of 116
confirmed CD patients were included in the study. Their ages ranged between 3
and 78 years, with a mean (SD) of 22.7 (17.8) years. The age data showed
positive skewness, as ages below 20 years were more frequent. Gender
distribution showed female predominance, with 74 (64%) females and 42 (36%)
males. The majority (85%) were symptomatic, as opposed to 17 asymptomatic
patients who underwent investigation due to strong positive family history.
Eighty-one
patients (69.8%) had positive serum tTG IgA and/or IgG antibodies. Sixty
patients (51.7%) were vitamin D deficient, 41 (35.3%) were insufficient and 15
(12.9%) had sufficient vitamin D levels. Tables I and II.
All nine
patients (100%) who presented with short stature had a deficient or
insufficient 25(OH)D3 level. Data for serum 25(OH)D3 and anti-tTG IgA and IgG
levels were not normally distributed. Correlation analysis found no significant
correlation between age, gender, vitamin D or tTG antibody level, with p > 0.05. Only one significant
positive correlation was found between tTG IgA and IgG antibodies, with a p value of 0.009.
Table
I: The frequency of demographic and serologic
parameters among CD patients.
Variable
|
Categories
|
Frequency
|
Percent (%)
|
Gender
|
Male
|
42
|
36.2
|
Female
|
74
|
63.8
|
Vitamin D level*
|
Deficient
|
60
|
51.7
|
Insufficient
|
41
|
35.3
|
Sufficient
|
15
|
12.9
|
Anti tTg antibodies**
|
Positive
|
81
|
69.8
|
Negative
|
35
|
30.2
|
Symptoms
|
Symptomatic
|
99
|
85.3
|
Asymptomatic
|
17
|
14.7
|
* Vitamin D deficient [25(OH)D3 < 20 ng/ml],
insufficient [25(OH)D3 20–30 ng/ml] and sufficient [25(OH)D3 >30 ng/ml].
** Positive at values of > 10 U/ml and >
9 U/ml for IgA and IgG, respectively.
Table
II: Clinical manifestations in celiac
disease, in percent
|
Children/adolescent (%)
|
Adults (%)
|
Chronic
diarrhea
|
55
|
45
|
Abdominal
pain
|
30
|
20
|
Anemia
|
14
|
52
|
Short stature
|
16.6
|
-
|
Failure to
thrive
|
25
|
35*
|
Hypoalbuminemia**
|
25.5
|
36
|
Asymptomatic
|
7.4
|
22
|
*Weight loss.
** Albumin less than 2.5g/dl.
DISCUSSION
CD is a common enteropathy and Nusier et
al. estimated the serological prevalence to be 1:124 in Jordanian
schoolchildren (7). A study conducted by Rawashdeh et al. (8) confirmed to the
well-known female preponderance in CD, similar to our results, whereas Al
Tamimi (9) found a slight male preponderance in CD children in south Jordan.
A conditional
recommendation by the American College of Gastroenterology was to assess
micronutrient levels in CD patients, including vitamin D (10). Malabsorption of
vitamin D and decreased bone density are seen in two-thirds of CD patients:
between 9% and 72%, depending on the population and compliance to diet (11,12).
A review by Di Nardo et al. showed an increased risk of inadequate vitamin D
consumption in CD children, regardless of diet restriction (13). Our current
study found 25(OH)D3 < 30 ng/ml in 87% of patients with CD.
Anti tTG
antibodies and clinical symptoms absent in CD patients as in 30% and 15%
of patients, respectively. This
emphasizes the importance of family screening and the diagnostic role of
duodenal biopsy.
In comparison with the general population of
Jordan, Khasawneh et al. calculated a slightly lower rate (68%) of insufficient
and deficient vitamin D levels, whereas Batieha et al. found a much lower rate
of 37.3% in females and 5.1% in males (14,15). We did not find a significant
difference based on gender. An interesting finding, however, was that all of
the patients who presented with short stature had low vitamin D levels.
With regard to
age, Lerner et al. suggested a negative correlation with vitamin D serum levels
in CD patients (16). In the present study, however, no relation was found
between vitamin D level and age. Furthermore, no relation was found with
anti-tTG antibody levels.
Further
prospective analyses to determine the effect of diet compliance on vitamin D
level, antibody status as well as other mal-absorption related parameters are
needed.
Unfortunately,
one of the limitations of this analysis was that no control group was included
CONCLUSION
Vitamin D
deficiency and insufficiency are common in CD patients, with no relation to
age, gender or tTG antibody levels.
Abbreviations
CD coeliac disease
25(OH)D3 25-hydroxyvitamin D3
tTG tissue
transglutaminase
REFERENCES
- Troncone R, Shamir R. Celiac disease. In:
Kliegman, RM, Gema ST, Blum NJ, Shah SS, Tasker RC, Wilson KM, et al.,
editors. Nelson Textbook of
Pediatrics, 21st edn. Philadelphia, PA: Saunders Elsevier; 2019, pp.
7909-25.
- Hill ID, Dirks MH, Liptak GS,
Colletti RB, Fasano A, Guandalini S, et al. Guideline for the diagnosis
and treatment of celiac disease in children: Recommendations of the North
American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
J. Pediatr. Gastroenterol. Nutr. 2005;40(1):1-19.
- Parzanese I, Qehajaj D,
Patrinicola F, Aralica M, Chiriva-Internati M, Stifter S, et al. Celiac disease: From
pathophysiology to treatment. World
J. Gastrointest. Pathophysiol. 2017;8(2):27-38.
- De Re V, Magris R, Cannizzaro
R. New
Insights into the pathogenesis of celiac disease. Front. Med. (Lausanne) 2017;4:137.
- Fody EP. Pancreatic function
and gastrointestinal function. In: Michael LB, Edward PF, Larry ES,
editors. Clinical Chemistry:
Techniques, Principles, Correlations, 6th edn. Philadelphia, PA:
Lippincott Williams & Wilkins; 2010, pp. 578-90.
- Marsh MN. Gluten, major
histocompatibility complex, and the small intestine: A molecular and immunobiologic
approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992;102:330-54.
- Nusier MK, Brodtkorb HK, Rein
SE, Odeh A, Radaideh AM, Klungland H. Serological screening for celiac disease
in schoolchildren in Jordan: Is height and weight affected when
seropositive? Ital. J. Pediatr.
2010;36:16.
- Rawashdeh MO1, Khalil B,
Raweily E. Celiac disease in Arabs. J. Pediatr. Gastroenterol. Nutr. 1996;
23(4):415-18.
- Altamimi E. Celiac disease in south
Jordan. Pediatr. Gastroenterol.
Hepatol. Nutr. 2017;20(4):222-6.
- Rubio-Tapia A, Hill ID, Kelly
CP, Calderwood AH, Murray JA. American College of
Gastroenterology. ACG clinical guidelines: Diagnosis and management of
celiac disease. Am. J.
Gastroenterol. 2013;108:656-7.
- Meyer D, Stavropolous S,
Diamond B, Shane E, Green PH. Osteoporosis in a North
American adult population with celiac disease. Am. J. Gastroenterol. 2001;96(1):112-19.
- Larussa T, Suraci E, Nazionale I, Abenavoli L, Imeneo M, Luzza
F. Bone
mineralization in celiac disease. Gastroenterol Res Pract. 2012; 2012.
[cited 2020 Mar 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/22737164/.
- Di Nardo G, Villa MP, Conti L,
Ranucci G, Pacchiarotti C, Principessa L, et al. Nutritional deficiencies in
children with celiac disease resulting from a gluten-free diet: A
systematic review. Nutrients 2019;11(7):1588.
- Khasawneh R, Hiari M, Khalaileh
M, Khasawneh H, Alzghoul B, Almomani A. Frequency of vitamin D deficiency and
insufficiency in a Jordanian cohort: A hospital based study. J. Roy. Med. Serv. 2018;
25(1):23-26.
- Batieha A, Khader Y, Jaddou H,
Hyassat D, Batieha Z, Khateeb M, et al. Vitamin D status in Jordan: Dress style
and gender discrepancies. Ann. Nutr.
Metab. 2011; 58(1):10-18.
- Lerner A, Shapira Y,
Agmon-Levin N, Pacht A, Ben-Ami Shor D, López HM, et al. The clinical significance of
25OH-Vitamin D status in celiac disease. Clin. Rev. Allergy Immunol. 2012;42(3):322-30.